AlphaYou
Overview
Smart money at a glance
Filings to Sep 26, 2026Net selling: insiders sold $16M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $22K to $128K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$16M netNet selling
- CongressSTOCK Act, last 180 days
- +$22K to +$128K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 25- Open
- $1,185.32
- 52-wk high
- $1,292.65
- High
- $1,190.00
- 52-wk low
- $711.59
- Low
- $1,160.84
- Prev close
- $1,181.89
- Mkt cap
- $1.05T
- P/E
- 38.6x
- Volume
- 1.92M
- Fwd P/E
- 24.4x
- Beta
- 0.50
- Div yield
- 0.56%
- P/S
- 13.2x
- P/B
- 30.3x
- Profit margin
- +33.5%
- Op margin
- +54.2%
- ROE
- +102.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LLY filings
Are insiders buying or selling Eli Lilly and Company (LLY) stock?
Net selling: insiders sold $16M and bought $0 of LLY stock on the open market in the 90 days to Sep 26, 2026, according to SEC Form 4 filings. $16M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Jonsson, Patrik (EVP & President, LLY Int'l), who sold $7.6M. The latest filing was on Aug 18, 2026.
Which members of Congress have traded LLY recently?
Rep. Michael Rulli (R) sold $1K to $15K on Jul 1, 2026, disclosed 37 days later. Rep. Gilbert Cisneros (D) bought $50K to $100K on Jun 10, 2026, disclosed 22 days later. Rep. Elizabeth Fletcher (D) sold $1K to $15K on Apr 8, 2026, disclosed 23 days later. Rep. Byron Donalds (R) bought $1K to $15K on Apr 2, 2026, disclosed 41 days later. In total, 4 members disclosed 5 LLY trades with trade dates in the last 180 days, filed a median 37 days after trading.
How current is this LLY smart-money data?
This summary uses filings available on Sep 26, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$911.7M
added
- SU
Susquehanna
$282.2M
added
Sells/Trims (1)
- QR
Qube Research
$242.1M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
Trader E15Short
$459K
position
Trader 295Long
$39K
position
Trader 232Short
$26K
position
Show all 5 positionsShow fewer positions
Trader 2EEShort
$23K
position
Trader 5B7Short
$21K
position
Activist stakes, short interest & more
Earnings
Earnings came in 39.4% above what analysts expected.
Earnings per share
$6.01 expected
GAAP EPS was $7.94 and adjusted EPS was $8.38. The analyst basis could not be confirmed, so no beat or miss is shown.
FY2026 guidance
$85.00B to $87.00B
No comparable estimate
Reports Oct 29, 2026, in 33 days
Estimates as of Sep 25, 2026
EPS expected
$8.95 to $11.30
Revenue expected
15 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $17.60B | $19.29B | $19.80B | $22.97B |
| Cost of what it sold | $3.01B | $3.37B | $3.58B | $3.27B |
| Gross profit | $14.59B | $15.92B | $16.22B | $19.71B |
| What it spent | ||||
| Research and development | $3.47B | $3.80B | $3.51B | $3.82B |
| Sales and admin | $2.74B | $3.34B | $2.93B | $3.43B |
| Other operating costs | — | -$212.1M | — | — |
| Total operating expenses | $6.21B | $6.93B | $6.44B | $7.25B |
| What was left | ||||
| Operating profit | $8.39B | $8.99B | $9.78B | $12.46B |
| Interest on debt | $179.6M | $123.0M | $332.0M | $345.0M |
| Profit before tax | $7.23B | $8.27B | $8.85B | $9.25B |
| Tax | $1.65B | $1.63B | $1.45B | $2.15B |
| Net profit | $5.58B | $6.64B | $7.40B | $7.09B |
| EBITDA | $7.88B | $12.14B | $10.29B | $12.99B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Can Johnson & Johnson (JNJ) Justify A Discount To Cash Flow?
NeutralSep 24Tyra Biosciences (NASDAQ:TYRA) Trading Down 6.7% on Analyst Downgrade
Leans bullishSep 23ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
Leans bullishSep 23Eli Lilly and Co. stock gains as Houston plant expands GLP-1 capacity
BullishSep 23GLP-1 Users Are Furious After Employers Drop Insurance Benefits
Leans bearishSep 23Eli Lilly Could Be a ‘$2,000 Stock’ in the Next 3 to 4 Years, Says Home Depot Co-Founder Ken Langone
BullishSep 23Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
Leans bullishSep 23Novo and Lilly Challenged: Viking Stock Surges on Weight-Loss Drug Trial
NeutralSep 22
Macro
31 macro signals shaping LLY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results